Frederik H. Verbrugge is a Cardiologist/Intensive Care physician with dedicated interest in heart failure, (exercise) hemodynamics & cardiorenal physiology. Prof. Dr. Verbrugge graduated as M.D. in 2010 (KU Leuven, Belgium), obtained his Ph.D. in 2015 (Hasselt University, Belgium) & received an M.Sc. in Clinical Trials in 2022 (Oxford University, UK). He is currently employed as Clinic Head/Clinical Professor at University Hospital Brussels/Vrije Universiteit Brussel (Belgium), where he cares for patients with heart failure & cardiac devices, attends the cardiac intensive care unit, and runs the exercise physiology lab. For his research, Prof. Dr. Verbrugge has an affiliation with the Department of Cardiovascular Diseases of the Mayo Clinic (Rochester, MN, US). He currently serves as Deputy Editor for European Heart Journal: Acute Cardiovascular Care and Editorial Consultant for JACC: Heart Failure.


RECENT PUBLICATIONS

Mullens W, Dauw J, Martens P, et al. Acetazolamide in Acute Decompensated Heart Failure with Volume Overload. N Engl J Med. 2022;387(13):1185-1195. doi:10.1056/NEJMoa2203094

Verbrugge FH, Martens P, Dauw J, et al. Natriuretic Response to Acetazolamide in Patients With Acute Heart Failure and Volume Overload. J Am Coll Cardiol. 2023;81(20):2013-2024. doi:10.1016/j.jacc.2023.03.400

Verwerft J, Soens L, Wynants J, et al. Heart failure with preserved ejection fraction: relevance of a dedicated dyspnoea clinic. Eur Heart J. 2023;44(17):1544-1556. doi:10.1093/eurheartj/ehad141